Israel’s Kadimastem is testing its technology for differentiating pluripotent stem cells into a range of functional human cells.

Stem-cell therapy for ALS, diabetes

By Guest Column Israel21c—— Bio and Archives--March 11, 2015

Lifestyles | Comments | Back To Full Article

A new stem-cell technology with the potential to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) is now in development by the Israel Prize laureate responsible for the blockbuster multiple sclerosis (MS) drug Rebif.

Read Full Article...

Welcome to CFP’s Comment Section!

The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.

Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.

Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.

We ask only that commenters keep it civil, keep it clean.

Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.

READ OUR Commenting Policy

CFP Comments

Commenting is not available in this channel entry.

Comments

Support Canada Free Press

Recommended by Canada Free Press